Avita Medical Ltd (RCEL)

[Billr05]

Blackcrane Capital Buys 4.3% of Avita Therapeutics Inc.
By Bloomberg Automation

(Bloomberg) -- Blackcrane Capital took a new position in Avita Therapeutics Inc. in the second quarter, buying 4.3 percent of the company's outstanding stock.

For the company's full holders list, click here.
The investment advisor bought 921,663 shares with a current market value of $21.5 million, according to its 13F filing with the Securities and Exchange Commission.

Blackcrane Capital LLC initiated one other position in the health care sector during the quarter, bringing its total to six companies. At the end of the quarter, they comprised 69 percent, or $61.3 million, of the investment advisor's total equity holdings of $88.4 million disclosed in the 13F.

Avita Therapeutics traded at $23.34, down 49 percent year to date.
Bloomberg analyzed more than 4,300 institutional investors that are required to disclose their U.S. equity investments to the Securities and Exchange Commission each quarter. An algorithm searched for investors that had reported purchasing at least 1 percent of a company's shares in its latest filing and showed no holdings in the stock in the previous filing.